Home  >  News
Eppendorf_eBook_Centrifuge_May25
you can get e-magazine links on WhatsApp. Click here
News
  BrainStorm gets US FDA nod to begin phase 3b trial of NurOwn to treat amyotrophic lateral sclerosis,   May 21, 2025
  Boehringer Ingelheim announces global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF & PPF, with similar discontinuation rates to placebo,   May 21, 2025
  Bharat Biotech’s oral cholera vaccine Hillchol demonstrates success in phase III clinical studies,   May 21, 2025
  UK MHRA highlights “remarkable” progress and launches real-world data consultation on International Clinical Trials Day,   May 21, 2025
  NovelMed announce positive 12-week interim results from phase II trial of Ruxoprubart in adult patients with PNH,   May 21, 2025
  Armata Pharma reports positive data from phase 1b/2a diSArm study of intravenously administered AP-SA02 to treat S. aureus bacteremia,   May 20, 2025
  IDeate-Esophageal01 phase 3 trial of ifinatamab deruxtecan initiated in certain patients with pretreated advanced or metastatic ESCC,   May 20, 2025
  Neutron Therapeutics & Helsinki University Hospital treat first head and neck cancer patients using accelerator-based boron neutron capture therapy,   May 19, 2025
  Merck to present new clinical and outcomes research data at the ATS 2025 international conference demonstrating commitment to advancing research in PAH,   May 19, 2025
  Vaxart gets BARDA nod to begin dosing in 10,000-participant portion of phase 2b Covid-19 clinical trial,   May 17, 2025
  New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline,   May 17, 2025
  Excision announces publication highlighting EBT-107 for treatment of chronic hepatitis B in bioRxiv,   May 16, 2025
  Foresee Pharma begins patient dosing in phase 2 WINDWARD study of mirivadelgat to treat pulmonary hypertension-associated interstitial lung disease,   May 16, 2025
  Merck’s phase 3 KEYNOTE-B96 trial meet primary endpoint of PFS in patients with platinum-resistant recurrent ovarian cancer whose tumours expressed PD-L1 and in all comers,   May 16, 2025
  OptymEdge launches first dedicated ophthalmology clinical trial platform,   May 15, 2025
  Hoth Therapeutics announces positive preclinical results for HT-KIT, a precision antisense therapy targeting rare and aggressive KIT-driven cancers,   May 14, 2025
  Newron Pharma gets US FDA nod for pivotal phase III ENIGMA-TRS programme with evenamide as add-on therapy in patients with treatment-resistant schizophrenia,   May 14, 2025
  AstraZeneca to showcase latest research on comprehensive portfolio and pipeline aimed at transforming respiratory diseases at ATS 2025,   May 14, 2025
  Ten-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer,   May 14, 2025
  Rein Therapeutics initiates RENEW phase 2 trial of LTI-03 in patients with idiopathic pulmonary fibrosis,   May 13, 2025

  • Results Found: 16229
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 812
 Back
 
Avians_2025
API_China_2025
CPHISEA25
worldadc-asia_25
ProPak_Asia_2025
CPHI_PMEC_China_2025
Pharmatech_Lab_Expo2025
CPHI_Hi_Korea_2025
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram